LMAM
WST icon

Legg Mason Asset Management’s West Pharmaceutical WST Stock Holding History

Legg Mason Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,417
Closed -$399K – 132
2021
Q1 		$399K Sell
1,417
-314
-18% -$89.9K 0.43% 105
2020
Q4 		$490K Buy
+1,731
New +$486K 0.49% 102
2020
Q2 		$419K Buy
+1,842
New +$362K 0.46% 101

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Legg Mason Asset Management's WST Position: Q2 2021 in Review

Legg Mason Asset Management sold out of West Pharmaceutical (WST) in Q2 2021, closing a stake of 1,417 shares — an estimated $399K sold.

Legg Mason Asset Management first reported a position in WST in Q2 2020 and held it in 3 quarters. The position peaked at $490K in Q4 2020. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

  • Legg Mason Asset Management reported no remaining West Pharmaceutical position as of Q2 2021 after selling out during the quarter.
  • Legg Mason Asset Management sold 1,417 West Pharmaceutical shares in Q2 2021, an estimated $399K.
  • Legg Mason Asset Management first reported a position in West Pharmaceutical in Q2 2020 and held it in 3 quarters.
  • Legg Mason Asset Management's West Pharmaceutical position peaked at $490K in Q4 2020.
  • 640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on Legg Mason Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.